Inflammation

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
Ragnhild Helseth, Ola Kleveland, Thor Ueland, Rune Wiseth, Jan Kristian Damas, Kaspar Broch, Annika Michelsen, Bjørn Bendz, Lars Gullestad, Pål Aukrust, Ingebjørg Seljeflot

Open Heart May 2021, 8 (1) e001492; DOI: 10.1136/openhrt-2020-001492
Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management
Isabella D Cooper, Catherine A P Crofts, James J DiNicolantonio, Aseem Malhotra, Bradley Elliott, Yvoni Kyriakidou, Kenneth H Brookler

Open Heart Sep 2020, 7 (2) e001356; DOI: 10.1136/openhrt-2020-001356
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
James J DiNicolantonio, Jorge Barroso-Arranda, Mark McCarty

Open Heart Sep 2020, 7 (2) e001350; DOI: 10.1136/openhrt-2020-001350
Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Margrethe Flesvig Holt, Bjørn E Seim, Jonas Øgaard, Maria B Olsen, Per R Woldbæk, John-Peder Escobar Kvitting, Pål Aukrust, Arne Yndestad, Tom Eirik Mollnes, Per H Nilsson, Mieke C Louwe, Trine Ranheim

Open Heart Nov 2019, 6 (2) e001098; DOI: 10.1136/openhrt-2019-001098
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, Kaspar Broch, Bjørn Bendz, Svend Aakhus, Thor Ueland, Brage H Amundsen, Jan Kristian Damås, Einar Hopp, Ola Kleveland, Knut Haakon Stensæth, Anders Opdahl, Nils-Einar Kløw, Ingebjørg Seljeflot, Geir Øystein Andersen, Rune Wiseth, Pål Aukrust, Lars Gullestad

Open Heart Oct 2019, 6 (2) e001108; DOI: 10.1136/openhrt-2019-001108
Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
Colin G Stirrat, Shirjel Alam, Thomas J MacGillivray, Calum Gray, Marc Richard Dweck, Victor Jones, William Wallace, John R Payne, Sanjay K Prasad, Roy S Gardner, Mark C Petrie, Saeed Mirsadraee, Peter Henriksen, David E Newby, Scott Semple

Open Heart Oct 2019, 6 (2) e001115; DOI: 10.1136/openhrt-2019-001115
Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
Ben Alencherry, Geoffrey Erem, Grace Mirembe, Isaac Ssinabulya, Chun-Ho Yun, Chung-Lieh Hung, Mark J Siedner, Marcio Bittencourt, Cissy Kityo, Grace A McComsey, Chris T Longenecker

Open Heart May 2019, 6 (1) e001046; DOI: 10.1136/openhrt-2019-001046
Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation
James J DiNicolantonio, James H O’Keefe

Open Heart Nov 2018, 5 (2) e000946; DOI: 10.1136/openhrt-2018-000946
Risk classification in primary prevention of CVD according to QRISK2 and JBS3 ‘heart age’, and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study
Ieuan Johns, Konstantinos E Moschonas, Jesús Medina, Nicholas Ossei-Gerning, George Kassianos, Julian P Halcox

Open Heart Nov 2018, 5 (2) e000849; DOI: 10.1136/openhrt-2018-000849
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
Thor Ueland, Ola Kleveland, Annika E Michelsen, Rune Wiseth, Jan Kristian Damås, Pål Aukrust, Lars Gullestad, Bente Halvorsen, Arne Yndestad

Open Heart Sep 2018, 5 (2) e000765; DOI: 10.1136/openhrt-2017-000765

Main menu

Inflammation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Inflammation

Pages